Literature DB >> 25310085

Regulatory framework for access to safe, effective quality medicines.

Lembit Rägo1, Hiiti Sillo, Ellen 't Hoen, Monika Zweygarth.   

Abstract

Medicines of uncertain quality, safety and efficacy can be worse than no treatment at all. It is the responsibility of national medicines regulatory authorities to protect patients from harm. Yet, there are great disparities in regulatory capacity globally, preventing large populations from accessing the benefits of advances in the pharmaceutical field. This article describes the main regulatory functions and how they are applied to assure the quality, safety and efficacy of different types of medicines in different environments. It gives examples of initiatives that have increased access to good quality medicines worldwide and - more importantly - are laying the groundwork for collaborative approaches aiming to ensure that pharmaceutical products meet the same, stringent quality standards in all parts of the world.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25310085     DOI: 10.3851/IMP2902

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  7 in total

Review 1.  Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.

Authors:  Ibrahim N Muhsen; Shahrukh K Hashmi; Dietger Niederwieser; Nicolaus Kroeger; Samir Agrawal; Marcelo C Pasquini; Yoshiko Atsuta; Karen K Ballen; Adriana Seber; Wael Saber; Mohamed A Kharfan-Dabaja; Walid Rasheed; Shinichiro Okamoto; Nandita Khera; William A Wood; Mickey B C Koh; Hildegard Greinix; Yoshihisa Kodera; Jeff Szer; Mary M Horowitz; Daniel Weisdorf; Mahmoud Aljurf
Journal:  Bone Marrow Transplant       Date:  2019-09-04       Impact factor: 5.483

2.  Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.

Authors:  Vincent Ahonkhai; Samuel F Martins; Alexandre Portet; Murray Lumpkin; Dan Hartman
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

3.  Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon.

Authors:  M P Ngogang Djobet; David Singhe; Julienne Lohoue; Christopher Kuaban; Jeanne Ngogang; Ernest Tambo
Journal:  AIDS Res Ther       Date:  2017-04-04       Impact factor: 2.250

4.  Generic substitution of antiretrovirals: patients' and health care providers' opinions.

Authors:  Jennifer A Kieran; Eimear O'Reilly; Siobhan O'Dea; Colm Bergin; Aisling O'Leary
Journal:  Int J STD AIDS       Date:  2017-03-02       Impact factor: 1.359

5.  Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.

Authors:  Margareth Ndomondo-Sigonda; Jacqueline Miot; Shan Naidoo; Nelson E Masota; Brian Ng'andu; Nancy Ngum; Eliangiringa Kaale
Journal:  BMC Public Health       Date:  2021-01-21       Impact factor: 3.295

Review 6.  Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review.

Authors:  Vijay Kumar Chattu; Vishal B Dave; K Srikanth Reddy; Bawa Singh; Biniyam Sahiledengle; Demisu Zenbaba Heyi; Cornelius Nattey; Daniel Atlaw; Kioko Jackson; Ziad El-Khatib; Akram Ali Eltom
Journal:  Int J Environ Res Public Health       Date:  2021-11-09       Impact factor: 3.390

7.  Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country.

Authors:  Nayyereh Ayati; Monireh Afzali; Mandana Hasanzad; Abbas Kebriaeezadeh; Ali Rajabzadeh; Shekoufeh Nikfar
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.